Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an open label trial for patients currently enrolled in other perifosine trials.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AEterna Zentaris
• Treatments: Tamoxifen; Trastuzumab

Criteria

Inclusion Criteria:

• Patients must be currently receiving treatment with perifosine on a previously approved protocol.

• Patients must have had at least one evaluation following the initiation of treatment and have stable disease, partial response or complete response.

• Patient is willing to sign a new consent Regarding the protocol no exclusion criteria are described.